NSEUpdates26 Jun 2026 · 26 Jun 2026, 02:35 pm

Updates

Marksans Pharma Limited · MARKSANS

✦ AI SummaryResults

Marksans Pharma Limited has submitted the machine-readable form/legible copy of its financial results for the quarter and year ended March 31, 2026, after initially submitting them in an incorrect format on May 26, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Limited has informed the Exchange regarding 'Machine Readable Form / Legible copy of Financial Results'.

Attachments (1)

📄

MARKSANS_26062026143512_Final_Results_machine_readable.pdf

pdf

Download →
View document text
Date: June 26, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS Sub: Update – Machine Readable/Legible copy of Financial Results Dear Sir/Madam, This is in reference to email dated June 24, 2026 received from the NSE, informing the Company that it has submitted the financial results for the quarter and year ended March 31, 2026, on May 26, 2026, which is not in Machine Readable Form / Legible copy. Thus, in continuation of the submission made by the Company on May 26, 2026 titled – ‘Outcome of the Board Meeting’, the Company is hereby submitting the Machine Readable Form / Legible copy of the financial results for the quarter and year ended March 31, 2026. Please note that the oversight was unintentional. The Company will ensure that such an occurrence is prevented in the future. We request you to note the aforesaid in your records. Thanking You, Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Enclosed as above Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com MSKA & Associates LLP HO 602, Floor 6, Raheja Titanium (Formerly known asM 5 KA & Associates) Western ExpressHighway, Geetanjali Railway Colony, RamNagar, Goregaon (E) Chartered Accountants Mumbai 400063, INDIA Tel: +912269740200 INDEPENDENTAUDITOR'S REPORT To the Boardof Directors of MarksansPharma Limited Report on the Audit of the Standalone Annual Financial Results Opinion We have audited the accompanyingstandalone annual financial results of MarksansPharma Limited (hereinafter referred to as 'the Company') for the year ended March 31, 2026, ('the Statement'), attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations'). In our opinion and to the best of our information and according to the explanations given to usthe aforesaidStatement: (i) is presentedin accordancewith the requirements of Regulation33of the Listing Regulationsin this regard; and (ii) givesatrue andfair view, in conformity with the recognition andmeasurementprinciples laid down in the applicable accounting standardsprescribed under Section133of the Companies Act, 2013('the Act'), readwithCompanies(IndianAccountingStandards)Rules, 2015, asamended,andotheraccounting principles generally accepted in India, of the net profit and other comprehensive income and other financial information of the Company for the year endedMarch31,2026. Basis for Opinion Weconducted our audit in accordance with the Standards on Auditing ('SAs') specified under section 143(10) of the Act. Our responsibilities under those SAs are further described in the Auditor's Responsibilities for the Audit of the standalone financial results section of our report. We are independent of the Company in accordancewith the Code of Ethicsissuedbythe Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the standalonefinancial statements under the provisionsof the Act andthe Rules thereunder, andwe have fulfilled ourotherethical responsibilitiesin accordancewith theserequirements andthe Codeof Ethics. Webelievethat the auditevidenceobtained byusissufficient andappropriateto provideabasis for our opinion. Management's andBoard of Directors' Responsibilitiesfor the StandaloneFinancial Results This Statement hasbeen prepared on the basis of the standalone annual financial statements. The Company's Management andBoardof Directors are responsiblefor the preparation andpresentation of this Statement that givesa true and fair view of the net profit, andother comprehensiveincome and RegisteredOffice: 602,RahejaTitanium, Western ExpressHighway, Goregaon(East),Mumbai-400063,Maharashtra, India Tel: +91 2269740200 ILLPIN:ACT-3789 Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kechi I Kolkata I Pune www.mska,in MSKA 8: Associates LLP (Formerly known asM 5 KA &: Associates) Chartered Accountants other financial information in accordancewith the recognition andmeasurementprinciples laid downin the applicable AccountingStandardsprescribed underSection133oftheAct readwithCompanies(Indian Accounting Standards) Rules, 2015, asamendedand other accounting principles generally accepted in India and is in compliance with the Regulation 33 of the Listing Regulations. This responsibility also includes maintenance of adequate accounting recordsin accordancewith the provisionsof the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completenessof the accounting records, relevant to the preparation andpresentation of the Statement that giveatrue andfairview andare free from material misstatement, whetherdueto fraud or error. In preparing the Statement, the Board of Directors of the Company are responsible for assessing the abilityof the Company to continue asagoingconcern, disclosing,asapplicable, matters related to going concernandusingthe goingconcernbasisof accounting unless the Board of Directors either intends to liquidatethe Company or to ceaseoperations, or hasnorealistic alternative but to doso. TheBoardof Directorsarealsoresponsibleforoverseeingthefinancial reporting processofthe Company. Auditor's Responsibilities for the Audit ofthe Standalone Financial Results Ourobjectives are to obtain reasonableassurance about whether the Statement asawhole is free from materialmisstatement, whether dueto fraud or error, andto issueanauditor's report that includes our opinion. Reasonableassuranceisahighlevel of assurance, butisnot aguaranteethatanauditconducted in accordancewith SAs will alwaysdetect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonablybeexpected toinfluencethe economicdecisionsofuserstakenonthebasisofthis Statement. As part of anaudit in accordancewith SAs, weexerciseprofessionaljudgmentandmaintain professional skepticism throughout the audit. Wealso: • Identifyandassess the risksof material misstatement of the Statement, whetherdueto fraud or error, designandperform audit proceduresresponsive to thoserisks, andobtain audit evidence that is sufficient andappropriate to provide a basis for our opinion. Therisk of not detecting a material misstatement resulting from fraud is higherthan for oneresulting from error, asfraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. • Obtain an understanding of internal control relevant to the audit in order to design audit proceduresthat are appropriate in the circumstances. UnderSection 143(3) (i) of the Act, we are alsoresponsiblefor expressing our opinion onwhether the Company hasadequate internal financial controls with reference to standalonefinancial statements in place andthe operating effectiveness of such controls. RegisteredOffice: 602,RahejaTItanium,WesternExpressHighway, Goregaon(East),Mumbai-400063,Maharashtra, India Tel: +912269740200 ILLPIN:ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennail Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai I Pune www,mska,jn MSKA & Associates LLP (Formerly known asM 5 KA & Assoc [Showing first 8,000 characters — download PDF for full document]